Healthcare

Global AI-Enabled Drug Discovery and Clinical Trials Market

March 28, 2020
ID: SR/HC-13
Format:Pdf
Pages:220

Global AI-Enabled Drug Discovery and Clinical Trials Market by Component (Solutions and Services), By Solution (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases, Immunologic Diseases, Infectious Diseases and Others), By End-User(Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast to 2020 to 2027

Description

Global AI-Enabled Drug Discovery and Clinical Trials Market Overview

The use of artificial intelligence (AI) technology can improve research and development efficiency and reduce cost investment to a certain extent. The design, discovery, and development of new drugs will also be shortened. The use of AI is to develop new drugs as it simulates the process of drug screening by computer, to predict the activity of compounds, and to conduct targeted physical screening of potential compounds. AI in the pharmaceutical industry mainly plays a supporting role, including drug mining, in-depth learning algorithm analysis of data, and prediction of new drug effectiveness, etc., to a certain extent, improve the efficiency of research and development, save money and reduce the risk of clinical trial failure.

AI uses big data and machine learning methods to propose the structural characteristics of drug targets and small molecule drugs from a large amount of information in papers, patents, and clinical experiments.

Global AI-Enabled Drug Discovery and Clinical Trials Market Insights

Global AI-Enabled Drug Discovery and Clinical Trials Market predicted to grow with a momentous rate during the forecast period, 2020-2027. The rise in demand for artificial intelligence to control drug discovery & development costs and reduce the overall time taken in this process would accelerate the growth of AI-enabled drug discovery and clinical trials market. Moreover, the growing application of AI to generate novel drug candidate, and aggregate and synthesize information will expand the AI-enabled drug discovery industry in the next few years. Additionally, AI in clinical trials improve the effectiveness of clinical trials and reduce cost, such as identifying the right classification of humans based on genomics, which leads to triggering the global AI-enabled clinical trials market in the future periods.

Artificial intelligence used to capture clinical data from multiple internal data sources to predict and monitor patient recruitment, cost, and quality of clinical trials. Also, the application of artificial intelligence technology in all stages of drug development: including deep feature selection, NLP in the target discovery stage; deep learning in the generation of new small molecule lead compounds; and clinical research on small molecules. Furthermore, the AI helping the drug industry by storing, manage, and trade life data: social network data, health data, and medical records.

Growth Driver

Increasing Adoption of Artificial Intelligence and Machine Learning in Drug Discovery and Clinical Trials Industry

The Artificial Intelligence has developed to assist the drug discovery industry, in several ways: predicting the outcome of a reaction with a given set of lead compounds, predicting the yield of a chemical reaction, and reverse-synthesizing planning. With the increase in computing power, AI will be able to introduce new treatments to the market at a much lower cost and at an amazing speed, without the need for large-scale infrastructure and investment. AI enables us to produce complex multi-targeted drugs, enabling one drug to treat multiple diseases.

AI has the potential to automatically find meaning patterns in large data sets, such as text, speech, or images. Natural language processing (NLP) can understand and correlate written or spoken language and the content of the human-machine interface (HMI), allowing natural information exchange between computers and humans.

Components Segmental Analysis

Based on components, the global AI-enabled drug discovery and clinical trials market bifurcated into Solutions and Services. The solutions segment predicted to gain a major share in the market by 2027, owing to the AI reduce timelines for drug discovery and improve the agility of the research process and surge the accuracy of predictions on the efficacy and safety of drugs.

The services segment will grow attributable to accelerate patient recruitment and identify patients who match complex trial criteria in minutes.

Solution Segmental Analysis

Based on the Solution, the global AI-Enabled drug discovery and clinical trials market classified into Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research, and Others. The Drug Design segment projected to register higher CAGR due to the AI helps companies to build capability, which mixes human expertise with an understanding of data and technology and secure buy-in and ensure these are used correctly.

The Clinical Trials segment will influence owing to the benefits of AI, such as improving data quality, increasing patient compliance & retention, and identifying treatment efficacy more efficiently and reliably than ever before.

Application Segmental Analysis

Based on application, the global AI-Enabled Drug Discovery and Clinical Trials market classified into Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases Immunologic Diseases, Infectious Diseases, and Others. The Oncology segment estimated to generate maximum revenue by 2027, as AI is helpful for cancer treatment such as Cancer Imaging, identify optimal treatments, enabling early diagnosis and interventions, and enable faster development of life-saving drugs.

The security & Surveillance segment will grow by the benefits of AI, such as clinicians diagnose disease and optimize treatment processes.

End-User Segmental Analysis

Based on end-user, the global AI-enabled drug discovery and clinical trials market categorized into Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers. Biopharmaceutical Industry segment expected to lead the market on account of the AI help in developing new drugs, predict untested components researchers should explore to find new cures and automated data gathering and analysis to create solutions to some of the most complex diseases.

The industrial segment will drive by application of AI, which helps in finding better clinical trials.

Region Segmental Analysis

Based on geography, the global AI-Enabled Drug Discovery and Clinical Trials market segmented into North America, Asia Pacific, Europe, South America, and Middle East & Africa. North America estimated to occupy the lion’s market share by 2027, owing to the growing demand for AI in the medical, healthcare system, and pharma sector, coupled with the USA government spending more budget on health systems.

The Asia Pacific will drive by the surge in chronic diseases coupled the developing countries like China and India, giving financial support to the healthcare industry.

Competitor Analysis

Companies such as Accutar Biotechnology Inc., AiCure, LLC, Ardigen, Atomwise, Inc, BenevolentAI, Berg LLC, Berkeley Lights, Inc., BioAge Labs, Inc., C4X Discovery Holdings Plc, Clinithink Ltd, Cloud Pharmaceuticals, Inc., Cyclica, Inc., CytoReason, and Symphony Innovation, LLC are the key players in the Global AI-Enabled Drug Discovery and Clinical Trials Market.

Key Stakeholders

Market research and consulting firms
Industry associations
Global AI-Enabled Drug Discovery and Clinical Trials providing firms
Research organizations and consulting companies
Organizations, associations, and alliances related to AI-Enabled Drug Discovery and Clinical Trials
Regulatory bodies

Scope of the report

Report Attribute	Details
Market size value in 2020	USD 370 million
Revenue forecast in 2027	USD 2925 million
Growth Rate	CAGR of 38.65% from 2020 to 2027
Historical data	2017-2019
Forecast period	2021 – 2027
Region covered	North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Key companies Profiled	Accutar Biotechnology Inc., BioAge Labs, Inc., C4X Discovery Holdings Plc, Clinithink Ltd, Cloud Pharmaceuticals, Inc., AiCure, LLC, Ardigen, Atomwise, Inc, BenevolentAI, Berg LLC, Berkeley Lights, Inc., Cyclica, Inc., CytoReason, and Symphony Innovation, LLC

Recent Developments

In September 2021, Owkin partnered with Actelion Pharmaceuticals Ltd. to manufacture innovative methods with the potential to augment AI-enabled external control arms.
In September 2021, Swift Medical’s launched Swift Scientific to expand the digital wound care company into decentralized trials.
In September 2021, Sensyne Health signed a non-exclusive strategic research agreement with Great Ormond Street Hospital for Children (GOSH) to drive research into childhood disease through ethical AI applications.

The objective of the Research

Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.

Market Modelling

By Component

Solution
Services

By Solution

By Applications

By End-User

Biopharmaceutical Industry
Contract Research Organizations (CROs)
Academic Institutes and Research Centers

By Region

North America
Europe
Asia Pacific
South America
Middle East & Africa

Table Of Contents

Methodology

Request Sample

Frequently Asked Questions (FAQ):

How is AI used for drug discovery and clinical trials?

AI is used for drug discovery and clinical trials by predicting the 3D protein structure, collecting and analyzing Real World Data and developing novel patient-centered endpoints.

What are the growth drivers of the Global AI-Enabled Drug Discovery and Clinical Trials Market?

The rising use of Machine Learning and Artificial Intelligence and reduced cost investment are the growth drivers of the global AI-Enabled Drug Discovery and Clinical Trials, Market.

What is the growth rate of the Global AI-Enabled Drug Discovery and Clinical Trials Market?

The growth rate of the Global AI-Enabled Drug Discovery and Clinical Trials Market is 38.65% from 2021 to 2027.

What is the size of the AI-Enabled Drug Discovery and Clinical Trials Market?

The size of the AI-Enabled Drug Discovery and Clinical Trials Market is USD 370 million in 2020, which will reach USD 2925 million by 2027.

What is the competitive landscape of the AI-Enabled Drug Discovery and Clinical Trials Market?

Accutar Biotechnology Inc., BioAge Labs, Inc., C4X Discovery Holdings Plc, Clinithink Ltd, Cloud Pharmaceuticals, Inc., AiCure, LLC, Ardigen, Atomwise, Inc, BenevolentAI, Berg LLC, Berkeley Lights, Inc., Cyclica, Inc., CytoReason, and Symphony Innovation, LLC are the key players in the Global AI-Enabled Drug Discovery and Clinical Trials, Market.

Select License

We Accept

Analyst support

After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.

Customer satisfaction

According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.

Inimitable expertise

Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.

Assured quality

We have created a systematic way to determine standards and satisfy your expectations.

Instant delivery

Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.

Privacy policy

We understand the inkling of your privacy, we will never misuse your email address.

Custom research service

We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.

Quality & accuracy

We provide you with the accurate quality of the customized study of an exclusive report according to your research need.

Data visualization

As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.

Information security

We truly respect your privacy and promise to keep your personal and confidential information safe and secure.